First Trust Direct Indexing’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,644
Closed -$214K 844
2023
Q4
$214K Sell
4,644
-1,242
-21% -$52.8K 0.02% 695
2023
Q3
$253K Buy
+5,886
New +$274K 0.03% 570
2023
Q1
Sell
-4,612
Closed -$244K 719
2022
Q4
$244K Buy
+4,612
New +$227K 0.03% 572
2022
Q2
Sell
-4,319
Closed -$224K 682
2022
Q1
$224K Sell
4,319
-685
-14% -$35.4K 0.03% 592
2021
Q4
$295K Buy
5,004
+375
+8% +$21.5K 0.04% 497
2021
Q3
$254K Buy
+4,629
New +$258K 0.04% 528
2021
Q1
Sell
-314
Closed -$18K 855
2020
Q4
$18K Buy
+314
New +$16.8K ﹤0.01% 866

Other funds holding QGEN

First Trust Direct Indexing's QGEN Position: Q1 2024 in Review

First Trust Direct Indexing sold out of Qiagen (QGEN) in Q1 2024, closing a stake of 4,644 shares — an estimated $214K sold.

First Trust Direct Indexing first reported a position in QGEN in Q4 2020 and held it in 7 quarters. The position peaked at $295K in Q4 2021. 282 funds tracked by Wall St. Rank hold QGEN as of Q1 2024.

  • First Trust Direct Indexing reported no remaining Qiagen position as of Q1 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 4,644 Qiagen shares in Q1 2024, an estimated $214K.
  • First Trust Direct Indexing first reported a position in Qiagen in Q4 2020 and held it in 7 quarters.
  • First Trust Direct Indexing's Qiagen position peaked at $295K in Q4 2021.
  • 282 funds tracked by Wall St. Rank held Qiagen as of Q1 2024.

Based on First Trust Direct Indexing's 13F filing for Q1 2024, filed 19 Apr 2024.